Longevity Health Holdings, Inc. has issued a $1.25 million senior secured convertible note following a settlement agreement with Puritan Partners. This development enhances its financial position and provides more room for future funding efforts.

Key Highlights

  • Longevity Health holds a new senior secured note totaling $1.25 million at a 10% interest rate.
  • Settlement agreement resolves litigation linked to a $1.25 million existing convertible note and a Warrant for 1,885,796 shares.
  • Notes are convertible at an initial price of $0.50 per share, with an alternative price option tied to market performance.

Longevity Health Holdings, Inc. has entered into a significant financial agreement with Puritan Partners LLC, issuing a $1.25 million senior secured convertible note on August 13, 2026. This settlement effectively mitigates Legal risks while providing a clear path forward for Longevity Health.

Settlement Details Finalized

The agreement reached between Longevity Health and Puritan Partners is comprehensive and addresses all disputes from prior litigation initiated by Puritan on November 8, 2023. Under the current settlement, Longevity Health has not only resolved the claims but has also acknowledged the outstanding balance on the original note of $1.25 million. In exchange for settling the existing note and warrant, Longevity will issue the new $1.25 million note.

This change simplifies the Capital Structure and marks a strategic shift toward resolution and growth for the company.

Note Structure and Terms

The newly issued note carries a 10% Interest Rate and has a Maturity date set for February 5, 2028. It is convertible into common stock at an initial price of $0.50 per share. An alternative conversion price can be selected by Puritan, set as 80% of the average closing trade prices over five days preceding a conversion date.

This flexibility allows Longevity Health potential future Equity Financing under varied market conditions. The company must prepare to prepay these notes using 25% of gross proceeds from specific future financing transactions, which emphasizes prudent financial management.

Implications for Financial Position

The new $1.25 million note reinforces Longevity Health's financial standing while interacting with Puritan Partners has broader implications for investor confidence. With public commitments to maintain authorized shares sufficient to cover four times the maximum conversion under this note, the company demonstrates a proactive approach to managing its equity profiles, engaging in strategic planning for future financing opportunities. The existence of cross-default provisions within the note further indicates a disciplined management philosophy to safeguard against financial missteps.

What Comes Next

This action will be a important step in enabling the company to tap into more capital while addressing the statutory requirements associated with the note. Investors will keenly observe how this situation evolves in the coming weeks and how it impacts the company’s strategic direction.